Health Technology · Pharmaceuticals: Major · NSE: VIYASH · data 2026-10-09

Viyash Scientific Limited

Health check: Average (6.3/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹234.06

Market cap

₹10,413 cr

P/E

57.2

P/B

—

ROE

9.8%

ROCE

12.4%

Debt / equity

0.17

Dividend yield

0.00%

1-year return

7.9%

52-week high

₹298

52-week low

₹178.13

Operating margin

12.9%

Growth

Revenue (last 12 months)	₹3,149 cr
Net profit (last 12 months)	₹171 cr
Sales growth, 3 years (yearly)	34.1%
Profit growth, 3 years (yearly)	—

Chart patterns

Double top — breakdown (key level ₹236.85)

Similar companies

Anupam Rasayan India Ltd. (ANURAS) · Corona Remedies Limited (CORONA) · Strides Pharma Science Ltd (STAR) · Blue Jet Healthcare Limited (BLUEJET) · Procter & Gamble Health Ltd. (PGHL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open VIYASH in NSE Scanner →